ArticleScientific reports2022

Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19.

Xiyuan Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.